1.
NOACs replace VKA as preferred oral anticoagulant among new patients: a drug utilization study in 560 pharmacies in The Netherlands
2.
3.
4.
5.
COST-EFFECTIVENESS OF MONITORING ENDOXIFEN LEVELS IN BREAST CANCER PATIENTS ADJUVANTLY TREATED WITH TAMOXIFEN
Health Care Resource Utilization and Expenditures of Incident Breast Cancer Patients in the Netherlands: Retrospective Analysis of Health Insurance Data